| AP SAN DIEGO (AP) -- Illumina Inc. said Wednesday that its board approved the buyback of up to $100 million of its outstanding shares. The genetic analysis instrument maker said the repurchases will be funded from existing cash. Illumina's $75 million buyback announced in August has been completed.
|  |
